VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Events
Capability Map
CoVPN 3004: Phase 3, SARS-CoV-2 Vaccine (Novavax)
Grant
Overview
date/time interval
September 1, 2020 - July 31, 2023
awarded by
National Institute of Allergy & Infectious Diseases
administered by
Medicine-Infectious Diseases
sponsor award ID
5 UM1 AI068619-14
Affiliation
contributor
Marks, Kristen
Principal Investigator (Subaward)
2020 - 2023